Maia BiotechnologyMAIA
13F holders, Q2 2025 (June 30)20holders
4new positions
4sold out
$1.73avg. 13F price*
At the end of Q2 2025, 20 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings, unchanged from Q1 2025. 4 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($2.1M), Centric Wealth Management ($872K) and Geode Capital Management, LLC ($400K).
- Company
- Maia Biotechnology Inc.
- CUSIP
- 552641102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $109K |
| Exits | 4 | $464K |
All 13F filers, Q1 2025 → Q2 2025: 1,110,041 shares bought and 302,956 shares sold, net +807,085 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | Add +75.4% | 1,140,769 | $2.1M |
| Centric Wealth Management | 0.21% | Add +740.2% | 573,398 | $872K |
| Geode Capital Management, LLC | 0.00% | Add +3.6% | 222,183 | $400K |
| BlackRock, Inc. | 0.00% | Add +22.8% | 103,265 | $186K |
| State Street Corp. | 0.00% | Add +41.9% | 75,550 | $136K |
| Northern Trust Corp. | 0.00% | No change | 39,032 | $70K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 36,000 | $65K |
| Jane Street Group, LLC | 0.00% | New | 28,783 | $52K |
| Marshall Wace, LLP | 0.00% | New | 16,165 | $29K |
| Centerpoint Advisory Group | 0.02% | New | 15,730 | $28K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 14,800 | $27K |
| Osaic Holdings, Inc. | 0.00% | Add +11.9% | 8,334 | $15K |
| Morgan Stanley | 0.00% | No change | 5,095 | $9K |
| UBS Group AG | 0.00% | Add +606.7% | 2,120 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +672.8% | 1,847 | $3K |
| MAI Capital Management | 0.00% | No change | 675 | $1K |
| Bank of America Corp. | 0.00% | Add +29.1% | 231 | $416 |
| Jones Financial Companies LLLP | 0.00% | No change | 228 | $404 |
| Raymond James Financial Inc. | 0.00% | New | 100 | $180 |
| JPMorgan Chase & Co. | 0.00% | Add +19.1% | 50 | $90 |
"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.